Consainsights logo
Reports / Anti-obesity Drugs Market

Anti-obesity Drugs Market

Anti-obesity Drugs Market Research Report – Segmented By Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs), Drug Type (OTC Drugs, Prescription Drugs) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Anti-obesity Drugs Market from Consainsights analyses the Anti-obesity Drugs Market in the Life Sciences industry over the forecast period to 2026.

Anti-obesity Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Anti-obesity Drugs segmentation includes Mechanism of Action, Drug Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Mechanism of Action, the Anti-obesity Drugs Market analysis covers Centrally Acting Drugs, Peripherally Acting Drugs.

Based on the Drug Type, the Anti-obesity Drugs Market analysis covers OTC Drugs, Prescription Drugs.

Key companies operating in the market include Arena Pharmaceuticals Inc., Alizyme, Bayer AG, Bristol-Myers Squibb, Currax Pharmaceuticals LLC, Eisai Co. Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co. Inc., Norgine BV, Novo Nordisk AS, Orexigen Therapeutics, Pfizer Inc., Rhythm Pharmaceuticals, Takeda Pharmaceuticals, Vivus Inc., Zafgan, Zydus Cadila and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Mechanism of Action (2019)
    Revenue Share (%), By Mechanism of Action (2019)
  • Revenue Share (%), By Drug Type (2019)
    Revenue Share (%), By Drug Type (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Mechanism of Action

By Mechanism of Action, The Global Anti-obesity Drugs Market analysis covers Centrally Acting Drugs, Peripherally Acting Drugs.

Global Anti-obesity Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Mechanism of Action, 2019-2027
Global Anti-obesity Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Mechanism of Action, 2019-2027

The Centrally Acting Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Centrally Acting Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
Centrally Acting Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)

The Peripherally Acting Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Peripherally Acting Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
Peripherally Acting Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
04

By Drug Type

By Drug Type, The Global Anti-obesity Drugs Market analysis covers OTC Drugs, Prescription Drugs.

Global Anti-obesity Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Type, 2019-2027
Global Anti-obesity Drugs Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Type, 2019-2027

The OTC Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OTC Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
OTC Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)

The Prescription Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Prescription Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
Prescription Drugs: Global Anti-obesity Drugs Market Revenue Opportunity (Us$ Mn)
05

North America

Based on the North America, the Anti-obesity Drugs Market analysis covers United States, Canada.

North America Map
North America Anti-obesity Drugs Market Size, 2019-2027 (Us$ Mn)
North America Anti-obesity Drugs Size, 2019-2027 (Us$ Mn)
North America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
North America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
North America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
North America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
United States Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
United States Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Canada Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Canada Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
06

Europe

Based on the Europe, the Anti-obesity Drugs Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Anti-obesity Drugs Market Size, 2019-2027 (Us$ Mn)
Europe Anti-obesity Drugs Size, 2019-2027 (Us$ Mn)
Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Germany Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Germany Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
United Kingdom Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
United Kingdom Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
France Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
France Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Spain Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Spain Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Russia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Russia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Italy Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Italy Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
07

Asia-Pacific

Based on the Asia-Pacific, the Anti-obesity Drugs Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Anti-obesity Drugs Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Anti-obesity Drugs Size, 2019-2027 (Us$ Mn)
Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
China Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
China Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Japan Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Japan Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
India Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
India Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Southeast Asia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Southeast Asia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Australia & New Zealand Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Australia & New Zealand Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Anti-obesity Drugs Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Anti-obesity Drugs Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Anti-obesity Drugs Size, 2019-2027 (Us$ Mn)
Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Middle East Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Middle East Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
09

Latin America

Based on the Latin America, the Anti-obesity Drugs Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Anti-obesity Drugs Market Size, 2019-2027 (Us$ Mn)
Latin America Anti-obesity Drugs Size, 2019-2027 (Us$ Mn)
Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Brazil Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Brazil Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Argentina Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Argentina Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Mexico Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Mexico Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Colombia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Colombia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Mechanism of Action, 2019-2027
Rest of Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Anti-obesity Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
10

Company Analysis

  • Arena Pharmaceuticals Inc.
  • Alizyme
  • Bayer AG
  • Bristol-Myers Squibb
  • Currax Pharmaceuticals LLC
  • Eisai Co. Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Norgine BV
  • Novo Nordisk AS
  • Orexigen Therapeutics
  • Pfizer Inc.
  • Rhythm Pharmaceuticals
  • Takeda Pharmaceuticals
  • Vivus Inc.
  • Zafgan
  • Zydus Cadila